Trials / Completed
CompletedNCT04064125
Dermal Cumulative Irritant Patch Study
A 21-Day, Randomized, Controlled Study to Evaluate the Skin Irritation Potential of FMX-101 in Healthy Volunteers Using a Cumulative Irritant Patch Test Design
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A 21-Day, Randomized, Controlled Study to Evaluate the Skin Irritation Potential of FMX-101 in Healthy Volunteers Using a Cumulative Irritant Patch Test Design
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FMX-101 |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2016-09-28
- Completion
- 2016-10-28
- First posted
- 2019-08-21
- Last updated
- 2019-08-28
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04064125. Inclusion in this directory is not an endorsement.